Literature DB >> 31176795

Connective tissue disease-associated interstitial lung disease and outcomes after hospitalization: A cohort study.

Ankush P Ratwani1, Kareem I Ahmad2, Scott D Barnett2, Steven D Nathan2, A Whitney Brown3.   

Abstract

BACKGROUND: The impact of hospitalization on patient outcomes is increasingly recognized and considered in the prognostication of many pulmonary disorders. We sought to evaluate the impact of hospitalization on survival in connective tissue disease-interstitial lung disease (CTD-ILD) patients.
METHODS: A chart review of patients with CTD-ILD followed at a tertiary care center was performed. Patients were stratified into two groups based on hospitalization status. Outcomes of the groups were compared using Kaplan-Meier survival analyses as well as multivariate competing risk analysis.
RESULTS: There were 137 patients identified with confirmed CTD-ILD. Patients who underwent hospitalization for any reason had a significant decrease in transplant-free survival compared to the never hospitalized cohort (3-year survival 60% vs. 94%; p = 0.0001). Hospitalization for ≥7 days was associated with worse outcomes than those hospitalized for <7 days (median survival 1.59 years vs. 7.17 years, p = 0.0012). Based on multivariate competing risk analysis, factors associated with death, with lung transplantation as a competing risk, were age (HR = 1.05 [95% 1.01-1.09]; P = 0.0443), male gender (HR = 4.94 [95% CI: 1.58-15.41]; P = 0.006), and all cause hospitalization (HR = 11.97 [95% CI: 1.36-105.49]; P = 0.0253).
CONCLUSION: This study highlights the impact of hospitalization on subsequent outcomes in the CTD-ILD population with a significantly reduced transplant-free survival demonstrated, especially after cardiopulmonary hospitalization events. Published by Elsevier Ltd.

Entities:  

Keywords:  Connective tissue disease interstitial lung disease; Hospitalization; Length of stay; Outcomes; Pulmonary fibrosis

Mesh:

Year:  2019        PMID: 31176795     DOI: 10.1016/j.rmed.2019.05.020

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  4 in total

1.  Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation.

Authors:  Lorriana E Leard; Are M Holm; Maryam Valapour; Allan R Glanville; Sandeep Attawar; Meghan Aversa; Silvia V Campos; Lillian M Christon; Marcelo Cypel; Göran Dellgren; Matthew G Hartwig; Siddhartha G Kapnadak; Nicholas A Kolaitis; Robert M Kotloff; Caroline M Patterson; Oksana A Shlobin; Patrick J Smith; Amparo Solé; Melinda Solomon; David Weill; Marlies S Wijsenbeek; Brigitte W M Willemse; Selim M Arcasoy; Kathleen J Ramos
Journal:  J Heart Lung Transplant       Date:  2021-07-24       Impact factor: 13.569

2.  Survival and outcomes after lung transplantation for connective tissue disease-associated interstitial lung diseases.

Authors:  Xiucheng Yang; Dong Wei; Mingzhao Liu; Bo Wu; Ji Zhang; Hongyang Xu; Shugao Ye; Feng Liu; Chunxiao Hu; Jingyu Chen
Journal:  Clin Rheumatol       Date:  2021-03-23       Impact factor: 2.980

3.  Causes of acute respiratory hospitalizations predict survival in fibrosing interstitial lung diseases.

Authors:  Johanna Salonen; Hannu Vähänikkilä; Minna Purokivi; Riitta Kaarteenaho
Journal:  PLoS One       Date:  2020-11-30       Impact factor: 3.240

4.  Usefulness of digital velcro crackles detection in identification of interstitial lung disease in patients with connective tissue diseases.

Authors:  Andreina Manfredi; Giulia Cassone; Caterina Vacchi; Fabrizio Pancaldi; Giovanni Della Casa; Stefania Cerri; Lisa De Pasquale; Fabrizio Luppi; Carlo Salvarani; Marco Sebastiani
Journal:  Arch Rheumatol       Date:  2020-06-25       Impact factor: 1.472

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.